Moxham Christopher
SEC CIK 1843784 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | CSO | 0 | — | $911.4K | 2 | 2021-08-10 | 2021-08-10 |
Most active insiders at FULC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA Capital Healthcare Fund LP | 10% | — | $58.38M |
| 2 | TANG KEVIN | 10% | $1.49M | — |
| 3 | Gould Robert J | Dir | — | $667.4K |
| 4 | Ezekowitz Alan | Dir | — | $65.6K |
| 5 | Oltmans Curtis Gale | CLO | — | $44.6K |
Moxham Christopher made no open-market trades at FULC in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10 | FULC | Fulcrum Therapeutics, Inc. | Moxham Christopher | CSO | S - Sale+OE | $17.60 | -51.8K | 0 | -100% | -$911.4K |
| DM | 2021-08-12 | 2021-08-10 | FULC | Fulcrum Therapeutics, Inc. | Moxham Christopher | CSO | M - OptEx | $7.84 | +51.8K | 20.7K | New | +$406.0K |
Purchase Sale Sale after option exercise All abbreviations